Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

Question 2

How does mapatumumab compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of the treatments in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for treatments and tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

Question 5

What should I expect during the treatment cycles?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

Question 6

Will participating in this trial affect my other treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer clinical trial (NCT00583830). Contact the study team or your healthcare provider for specific answers.

What this study is about